Assessment of biotechnology drugs: what are the issues?

J.E.F. Zwart - van Rijkom; H.G.M. Leufkens; D.J.A. Crommelin; F. Rutten; A.W. Broekmans

Assessment of biotechnology drugs: what are the issues?

J.E.F. Zwart - van Rijkom
, H.G.M. Leufkens
, D.J.A. Crommelin
, F. Rutten
, A.W. Broekmans

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	255-274
Number of pages	20
Journal	Health Policy
Volume	47
Publication status	Published - 1999

Keywords

Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{13b6236c40f04a4f976c174db3fa117e,

title = "Assessment of biotechnology drugs: what are the issues?",

keywords = "Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "\{Zwart - van Rijkom\}, J.E.F. and H.G.M. Leufkens and D.J.A. Crommelin and F. Rutten and A.W. Broekmans",

year = "1999",

language = "Undefined/Unknown",

volume = "47",

pages = "255--274",

journal = "Health Policy",